VTE Accreditation

PROGRAM DESCRIPTION
According to the Agency for Healthcare Research and Quality, provision of appropriate thromboprophylaxis is the number one strategy to improve patient safety in hospitals. Understanding the risk assessment to identify candidates for thromboprophylaxis and implementing evidence-based prophylactic anticoagulation regimens are imperative for all healthcare practitioners to optimize patient outcomes.

This interactive e-Case examines the burden of disease caused by VTE along with gaps in care, identification of patients at risk for VTE, guidelines for diagnosis, and evidence-based recommendations for appropriate anticoagulation interventions.

TARGET AUDIENCE
Nurse practitioners (NPs), physician assistants (PAs), and physicians

GOAL
To familiarize clinicians with the clinical burden of VTE in medical patients, the evidence supporting VTE management and prevention in current practice guidelines, and strategies for VTE prophylaxis and treatment in this at-risk group of patients.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be better able to:
•   Summarize the scope of the morbidity and mortality caused by venous thromboembolism
•   Identify hospitalized patients at risk for venous thromboembolism
•   Institute evidence-based prophylactic anticoagulation regimens

FACULTY
Franklin A. Michota Jr, MD
Director of Academic Affairs
Department of Hospital Medicine
Cleveland Clinic
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, Ohio

Brought to you by

ACCREDITATION
NYMC This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of New York Medical College (NYMC) and Continuing Education Alliance. NYMC is accredited by the ACCME to provide continuing medical education for physicians. NYMC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The estimated time to complete this activity is 0.5 hour.
Release date: August 25, 2010.
Expiration date: Required materials must be submitted before August 25, 2011.

This program is supported by an educational grant from sanofi-aventis U.S.

DISCLAIMER
The opinions or views expressed in this CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, New York Medical College, or sanofi-aventis U.S.

DISCLOSURES
All faculty and planners participating in continuing medical education activities sponsored by New York Medical College are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Michota: consultant/research grants: Genentech, Inc., Otsuka Pharmaceutical Co., Ltd., sanofi-aventis U.S.

The Planning Committee for this activity included Margaret Astrologo of New York Medical College and Ruth Cohen of Continuing Education Alliance. The members of the Planning Committee have no significant relationships to disclose.

Please contact Caitlin Prinsen at cprinsen@practicingclinicians.com for questions regarding this activity.